187 related articles for article (PubMed ID: 821491)
1. Identity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril in primary amyloidosis.
Block PJ; Skinner M; Benson MD; Cohen AS
Arthritis Rheum; 1976; 19(4):755-9. PubMed ID: 821491
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
4. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
[TBL] [Abstract][Full Text] [Related]
5. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
Olsen KE; Sandgren O; Sletten K; Westermark P
Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
[TBL] [Abstract][Full Text] [Related]
6. Structure and antigenic behaviour of kappa I-immunoglobulin light-chain amyloid proteins.
Westermark P; Sletten K; Natvig JB
Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):199-203. PubMed ID: 6171994
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin heavy-chain-associated amyloidosis.
Eulitz M; Weiss DT; Solomon A
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
[TBL] [Abstract][Full Text] [Related]
8. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
[TBL] [Abstract][Full Text] [Related]
9. A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues.
Foss GS; Nilsen R; Cornwell GC; Husby G; Sletten K
Scand J Immunol; 1998 Apr; 47(4):348-54. PubMed ID: 9600316
[TBL] [Abstract][Full Text] [Related]
10. Light chain amyloidosis of the urinary bladder. A site restricted deposition of an externally produced immunoglobulin.
Livneh A; Shtrasburg S; Martin BM; Baniel J; Gal R; Pras M
J Clin Pathol; 2001 Dec; 54(12):920-3. PubMed ID: 11729210
[TBL] [Abstract][Full Text] [Related]
11. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
[TBL] [Abstract][Full Text] [Related]
12. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
Linke RP; Geisel O; Mann K
Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
[TBL] [Abstract][Full Text] [Related]
13. Amyloid fibril protein AA in Papua New Guinean amyloidosis.
Anders RF; Price MA; Wilkey IS; Husby G; Takitaki F; Natvig JB; McAdam KP
Clin Exp Immunol; 1976 Apr; 24(1):49-53. PubMed ID: 820500
[TBL] [Abstract][Full Text] [Related]
14. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.
Swuec P; Lavatelli F; Tasaki M; Paissoni C; Rognoni P; Maritan M; Brambilla F; Milani P; Mauri P; Camilloni C; Palladini G; Merlini G; Ricagno S; Bolognesi M
Nat Commun; 2019 Mar; 10(1):1269. PubMed ID: 30894521
[TBL] [Abstract][Full Text] [Related]
15. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
Kitajima Y; Hirata H; Kagawa Y; Yaoita H
J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin-related (AL) amyloidosis.
Husby G
Clin Exp Rheumatol; 1983; 1(4):353-8. PubMed ID: 6442636
[TBL] [Abstract][Full Text] [Related]
17. A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.
Husby G
Scand J Rheumatol; 1980; 9(1):60-4. PubMed ID: 6769151
[TBL] [Abstract][Full Text] [Related]
18. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
[TBL] [Abstract][Full Text] [Related]
19. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
Elife; 2020 Mar; 9():. PubMed ID: 32151314
[TBL] [Abstract][Full Text] [Related]
20. Current concepts of the formation and composition of amyloid.
Glenner GG
Ann Clin Lab Sci; 1975; 5(4):257-63. PubMed ID: 808999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]